España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
BioCryst Pharma
BCRX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$7.60
0.11
1.47%
At close: -
$7.60
0
0.00%
After Hours: Nov 22, 6:41 PM EDT
Get Report
Comment
BioCryst Pharma (BCRX) Forecast
News
Earnings
BioCryst Pharma (BCRX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for BioCryst Pharma (NASDAQ:BCRX) Stock
BioCryst Pharma Stock (NASDAQ: BCRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 18, 2024
BioCryst's ORLADEYO Gets Ireland's Approval: ...
Benzinga Newsdesk
Tuesday, November 05, 2024
RBC Capital Reiterates Outperform on BioCryst...
Benzinga Newsdesk
Needham Reiterates Buy on BioCryst Pharma, Ma...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on BioCryst P...
Benzinga Newsdesk
Monday, November 04, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
BioCryst Pharma shares are trading lower foll...
Benzinga Newsdesk
BioCryst Adjusts ORLADEYO Revenue Guidance To...
Benzinga Newsdesk
BioCryst Pharma Q3 2024 GAAP EPS $(0.07) Miss...
Benzinga Newsdesk
Thursday, October 24, 2024
BioCryst Highlights Real-World Data Showing H...
Benzinga Newsdesk
Monday, October 14, 2024
BioCryst's ORLADEYO Reduces Hospital Visits a...
Benzinga Newsdesk
Wednesday, October 02, 2024
BioCryst Pharmaceuticals Has Enrolled The Fir...
Benzinga Newsdesk
Monday, September 30, 2024
The Us Department Of Health And Human Service...
Benzinga Newsdesk
Tuesday, September 17, 2024
BioCryst Pharmaceuticals Has Completed Negoti...
Benzinga Newsdesk
Friday, September 06, 2024
BioCryst Presents Results on HAE Treatment an...
Benzinga Newsdesk
Tuesday, August 06, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on BioCryst P...
Benzinga Newsdesk
RBC Capital Reiterates Outperform on BioCryst...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on BioCrys...
Benzinga Newsdesk
Monday, August 05, 2024
BioCryst Pharmaceuticals shares are trading h...
Benzinga Newsdesk
BioCryst Pharmaceuticals Says It Expects To A...
Benzinga Newsdesk
BioCryst Pharmaceuticals Has Raised Its 2024 ...
Benzinga Newsdesk
BioCryst Pharma Q2 2024 GAAP EPS $(0.06) Beat...
Benzinga Newsdesk
Sunday, June 02, 2024
BioCryst Announced Data Showing Reductions In Attack Rates In HAE Patients with Normal C1-Inhibitor After Beginning ORLADEYO Treatment
Charles Gross
Wednesday, May 15, 2024
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
BioCryst Pharmaceuticals Form 4 Filings Shows...
Benzinga Newsdesk
NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Thursday, May 09, 2024
BioCryst Presents New Real-world Evidence Sho...
Benzinga Newsdesk
Tuesday, May 07, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on BioCrys...
Benzinga Newsdesk
Needham Reiterates Buy on BioCryst Pharma, Ma...
Benzinga Newsdesk
Monday, May 06, 2024
BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
Vandana Singh
BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estimates
Zacks
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
BioCryst Pharma shares are trading higher fol...
Benzinga Newsdesk
Biocryst Forecasts 2024 Orladeyo Revenue Of $...
Benzinga Newsdesk
BioCryst Pharma Q1 2024 Adj EPS $(0.17) Beats...
Benzinga Newsdesk
Wednesday, April 17, 2024
BioCryst Pharmaceuticals Announced That The B...
Benzinga Newsdesk
Wednesday, April 10, 2024
Needham Reiterates Buy on BioCryst Pharma, Ma...
Benzinga Newsdesk
Monday, February 26, 2024
What's Going On With BioCryst Stock After Earnings?
Erica Kollmann
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Avi Kapoor
BioCryst Forecasts Fiscal Year 2024 Orladeyo ...
Benzinga Newsdesk
BioCryst Pharma Q4 Adjusted EPS $(0.28) Misse...
Benzinga Newsdesk
Earnings Scheduled For February 26, 2024
Benzinga Insights
Friday, February 23, 2024
A Preview Of BioCryst Pharma's Earnings
Benzinga Insights
BioCryst Pharmaceuticals Says New Analyses Of...
Benzinga Newsdesk
Tuesday, February 20, 2024
Reported Monday, BioCryst Launches ORLADEYO® ...
Benzinga Newsdesk
Monday, January 08, 2024
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
BioCryst Pharmaceuticals shares are trading h...
Benzinga Newsdesk
What's Going On With BioCryst Pharmaceuticals Stock?
Erica Kollmann
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch